Mounjaro: is a once-weekly injection that is FDA approved to be used to decrease blood sugar (blood glucose) in adults who have type 2 diabetes. It should be used together with diet and exercise. Mounjaro has also been shown in clinical trials to be useful for weight loss, however it is currently not an FDA approved weight loss drug.
Diabetes: is a long-term condition when your blood sugars (HbA1c) become too high because the body does not produce or use insulin normally. Overtime high blood sugars can cause serious health problems including heart disease, vision loss and kidney disease.
Mechanism of Action: Mounjaro works to reduce blood sugar levels by increasing your insulin production and also lowering the amount of sugar your liver makes. It also slows the rate food passes through your body which makes you feel full longer.
Features: Mounjaro (Tirzepatide) is the first dual GIP/GLP-1 receptor agonist which means it works on the glucose-dependent insulinotropic polypeptide (GIP) receptors and the glucagon-like peptide-1 (GLP-1) receptors.
Mounjaro can be used as a single therapy or with other diabetes medicines including metformin, sulfonylureas or SGLT2 inhibitors.
It is not known if this medicine can be used in people who have had pancreatitis. Mounjaro is not for use in people with type 1 diabetes.
